News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alimera Sciences (ALIM), pSivida Corp (PSDV) Rocket On FDA Labeling Talks For Eye Drug


12/19/2013 7:25:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

pSivida Corp and Alimera Sciences Inc said they would try a fourth time to get approval for an eye treatment for diabetes patients, sending the shares of both companies soaring. Alimera Sciences shares jumped 88 percent and pSivida stock climbed 62 percent in premarket trade. The drug-device combination, Iluvien, is a sustained-release eye implant used to treat vision loss associated with chronic diabetic macular edema (DME).

Help employers find you! Check out all the jobs and post your resume.

Read at BusinessWeek
Read at The Australian
Read at Wall Street Journal
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES